Forecast & Rating4 analysts currently cover LEADS BIOLABS-B, of which 3 give a positive rating. The average price target is HK$100.05, about 39.1% upside from the current price of HK$71.95. Coverage is limited, so the data is for reference only. Data as of Aug 21, 2026; this does not constitute investment advice.
Aug 20, 2026Price forecast
HK$100.0539.06%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 27, 2026
Forecast met62.2%
Stock price$71.95
Avg. target$100.1
High target$109
Low target$79
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.